A detailed history of F Dx Advisors, Inc. transactions in Pfizer Inc stock. As of the latest transaction made, F Dx Advisors, Inc. holds 9,034 shares of PFE stock, worth $248,073. This represents 0.07% of its overall portfolio holdings.

Number of Shares
9,034
Previous 8,927 1.2%
Holding current value
$248,073
Previous $250,000 4.4%
% of portfolio
0.07%
Previous 0.07%

Shares

32 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 04, 2024

BUY
$27.7 - $31.39 $2,963 - $3,358
107 Added 1.2%
9,034 $261,000
Q2 2024

Aug 02, 2024

SELL
$25.26 - $29.6 $83,484 - $97,828
-3,305 Reduced 27.02%
8,927 $250,000
Q1 2024

May 03, 2024

SELL
$25.89 - $29.73 $1.04 Million - $1.2 Million
-40,247 Reduced 76.69%
12,232 $339,000
Q4 2023

Feb 12, 2024

BUY
$26.13 - $33.94 $272,274 - $353,654
10,420 Added 24.77%
52,479 $1.51 Million
Q3 2023

Nov 02, 2023

SELL
$32.09 - $37.51 $518,959 - $606,611
-16,172 Reduced 27.77%
42,059 $1.4 Million
Q2 2023

Jul 17, 2023

SELL
$36.12 - $41.79 $2.66 Million - $3.08 Million
-73,645 Reduced 55.84%
58,231 $2.14 Million
Q4 2022

Feb 09, 2023

BUY
$41.75 - $54.5 $807,319 - $1.05 Million
19,337 Added 17.18%
131,876 $6.76 Million
Q3 2022

Nov 10, 2022

SELL
$43.76 - $53.42 $380,799 - $464,860
-8,702 Reduced 7.18%
112,539 $4.93 Million
Q2 2022

Aug 03, 2022

SELL
$46.53 - $55.17 $307,516 - $364,618
-6,609 Reduced 5.17%
121,241 $6.36 Million
Q1 2022

May 03, 2022

BUY
$45.75 - $56.69 $868,563 - $1.08 Million
18,985 Added 17.44%
127,850 $6.62 Million
Q4 2021

Feb 01, 2022

SELL
$41.32 - $61.25 $169,990 - $251,982
-4,114 Reduced 3.64%
108,865 $6.43 Million
Q3 2021

Oct 08, 2021

SELL
$39.25 - $50.42 $362,434 - $465,578
-9,234 Reduced 7.56%
112,979 $4.86 Million
Q2 2021

Aug 05, 2021

BUY
$35.91 - $40.68 $146,225 - $165,648
4,072 Added 3.45%
122,213 $4.79 Million
Q1 2021

Apr 14, 2021

BUY
$33.49 - $37.77 $3.81 Million - $4.3 Million
113,861 Added 2660.3%
118,141 $4.28 Million
Q1 2021

Apr 13, 2021

SELL
$33.49 - $37.77 $3.05 Million - $3.44 Million
-91,132 Reduced 95.51%
4,280 $155,000
Q4 2020

Feb 08, 2021

SELL
$33.47 - $42.56 $105,330 - $133,936
-3,147 Reduced 3.19%
95,412 $3.51 Million
Q3 2020

Nov 12, 2020

SELL
$31.75 - $37.25 $768,096 - $901,152
-24,192 Reduced 19.71%
98,559 $3.62 Million
Q2 2020

Jul 22, 2020

SELL
$30.12 - $36.54 $907,846 - $1.1 Million
-30,141 Reduced 19.71%
122,751 $4.01 Million
Q1 2020

May 22, 2020

BUY
$27.03 - $38.62 $3.86 Million - $5.52 Million
142,843 Added 1421.46%
152,892 $4.99 Million
Q1 2020

May 13, 2020

SELL
$27.03 - $38.62 $4.06 Million - $5.8 Million
-150,225 Reduced 93.73%
10,049 $15,000
Q4 2019

Feb 12, 2020

BUY
$32.92 - $37.36 $1.01 Million - $1.14 Million
30,561 Added 23.56%
160,274 $6.28 Million
Q3 2019

Nov 07, 2019

SELL
$32.49 - $42.13 $1.37 Million - $1.78 Million
-42,132 Reduced 24.52%
129,713 $4.66 Million
Q2 2019

Jul 19, 2019

SELL
$36.98 - $41.52 $44,782 - $50,280
-1,211 Reduced 0.7%
171,845 $7.44 Million
Q1 2019

May 14, 2019

BUY
$37.5 - $41.2 $2.02 Million - $2.22 Million
53,906 Added 45.24%
173,056 $7.35 Million
Q4 2018

Apr 29, 2019

SELL
$38.47 - $43.86 $5.48 Million - $6.25 Million
-142,439 Reduced 54.45%
119,150 $5.2 Million
Q4 2018

Feb 07, 2019

BUY
$38.47 - $43.86 $814,140 - $928,209
21,163 Added 8.8%
261,589 $11.4 Million
Q3 2018

Nov 13, 2018

SELL
$34.47 - $41.81 $98,515 - $119,492
-2,858 Reduced 1.17%
240,426 $10.6 Million
Q2 2018

Aug 08, 2018

SELL
$32.98 - $35.16 $4.57 Million - $4.87 Million
-138,520 Reduced 36.28%
243,284 $8.83 Million
Q1 2018

May 02, 2018

SELL
$31.91 - $37.02 $1.06 Million - $1.23 Million
-33,096 Reduced 7.98%
381,804 $13.6 Million
Q4 2017

Feb 09, 2018

BUY
$33.26 - $35.29 $418,011 - $443,524
12,568 Added 3.12%
414,900 $15 Million
Q3 2017

Nov 03, 2017

BUY
$31.0 - $34.15 $925,629 - $1.02 Million
29,859 Added 8.02%
402,332 $14.4 Million
Q2 2017

Aug 11, 2017

BUY
N/A
372,473
372,473 $12.5 Million

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $154B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track F Dx Advisors, Inc. Portfolio

Follow F Dx Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of F Dx Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on F Dx Advisors, Inc. with notifications on news.